drugset / Trial / NCT05799326

Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke

NCT05799326

Recruiting 100 enrolled Yi Yang
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of levofloxacin in treating acute ischemic stroke.

Timeline

Start
2023-06-30
Primary completion
2024-12-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 200 mg

Indications